Literature DB >> 17646205

Allergic conditions and brain tumor risk.

Annette Wigertz1, Stefan Lönn, Judith Schwartzbaum, Per Hall, Anssi Auvinen, Helle Collatz Christensen, Christoffer Johansen, Lars Klaeboe, Tiina Salminen, Minouk J Schoemaker, Anthony J Swerdlow, Tore Tynes, Maria Feychting.   

Abstract

An inverse association between allergic conditions and glioma risk has been reported previously. In this large population-based case-control study, the authors identified cases diagnosed with glioma or meningioma in Denmark, Norway, Finland, Sweden, and southeast England between 2000 and 2004. Detailed information on self-reported physician-diagnosed allergic conditions was collected from 1,527 glioma cases, 1,210 meningioma cases, and 3,309 randomly selected controls. Logistic regression showed an odds ratio of 0.70 (95% confidence interval: 0.61, 0.80) for glioma associated with a diagnosis of any of asthma, hay fever, eczema, or other type of allergy. The risk estimates for glioma were around 0.65 for each allergic condition (asthma, eczema, hay fever, and food allergy), and the 95% confidence intervals were equally consistent, at around 0.55, 0.80. The reduced risks of glioma related to eczema, hay fever, and allergy overall, but not asthma, were confined to current rather than past conditions. Meningioma risk was not associated with allergic conditions, except for eczema (odds ratio = 0.74, 95% confidence interval: 0.60, 0.91). Our results show a reduced risk for glioma associated primarily with current allergic conditions. If this is etiologic, it has implications for the understanding of how allergic conditions might reduce the tumor risk.

Entities:  

Mesh:

Year:  2007        PMID: 17646205     DOI: 10.1093/aje/kwm203

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  49 in total

1.  Selected human leukocyte antigen class II polymorphisms and risk of adult glioma.

Authors:  Bryan A Bassig; Peter D Inskip; Laurie Burdette; William R Shapiro; Robert G Selker; Howard A Fine; Jay S Loeffler; Peter M Black; Robert Dubrow; Alina V Brenner
Journal:  J Neuroimmunol       Date:  2010-12-30       Impact factor: 3.478

2.  Antihistamine use and immunoglobulin E levels in glioma risk and prognosis.

Authors:  E Susan Amirian; Deborah Marquez-Do; Melissa L Bondy; Michael E Scheurer
Journal:  Cancer Epidemiol       Date:  2013-08-30       Impact factor: 2.984

3.  Allergic conditions reduce the risk of glioma: a meta-analysis based on 128,936 subjects.

Authors:  Hongyu Zhao; Weisong Cai; Shitao Su; Debao Zhi; Jie Lu; Shuo Liu
Journal:  Tumour Biol       Date:  2013-12-18

4.  Association of the interleukin-4Rα rs1801275 and rs1805015 polymorphisms with glioma risk.

Authors:  Jun Guo; Lei Shi; Min Li; Jin Xu; Shushan Yan; Chuang Zhang; Guan Sun
Journal:  Tumour Biol       Date:  2013-08-27

5.  Nonsteroidal anti-inflammatory drugs and glioma in the NIH-AARP Diet and Health Study cohort.

Authors:  Sarah E Daugherty; Steven C Moore; Ruth M Pfeiffer; Peter D Inskip; Yikyung Park; Albert Hollenbeck; Preetha Rajaraman
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-01

6.  Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study.

Authors:  E Susan Amirian; Renke Zhou; Margaret R Wrensch; Sara H Olson; Michael E Scheurer; Dora Il'yasova; Daniel Lachance; Georgina N Armstrong; Lucie S McCoy; Ching C Lau; Elizabeth B Claus; Jill S Barnholtz-Sloan; Joellen Schildkraut; Francis Ali-Osman; Siegal Sadetzki; Christoffer Johansen; Richard S Houlston; Robert B Jenkins; Jonine L Bernstein; Ryan T Merrell; Faith G Davis; Rose Lai; Sanjay Shete; Christopher I Amos; Beatrice S Melin; Melissa L Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

7.  Cancers of the brain and CNS: global patterns and trends in incidence.

Authors:  Adalberto Miranda-Filho; Marion Piñeros; Isabelle Soerjomataram; Isabelle Deltour; Freddie Bray
Journal:  Neuro Oncol       Date:  2017-02-01       Impact factor: 12.300

8.  Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk.

Authors:  Karlyne M Reilly
Journal:  Brain Pathol       Date:  2009-01       Impact factor: 6.508

9.  Assessment of autoantibodies to meningioma in a population-based study.

Authors:  Joseph L Wiemels; Paige M Bracci; Margaret Wrensch; Joellen Schildkraut; Melissa Bondy; Jon Pfefferle; Mi Zhou; Jennette Sison; Lisa Calvocoressi; Elizabeth B Claus
Journal:  Am J Epidemiol       Date:  2012-12-06       Impact factor: 4.897

10.  Allergies and the Subsequent Risk of Cancer among Elderly Adults in the United States.

Authors:  Monica D'Arcy; Donna R Rivera; Andrew Grothen; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-30       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.